Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Identify index funds that offer best value for retirement by comparing costs, diversification, and potential returns, with practical fund picks.
27,007 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Option Care earnings season sheds light on the shifting landscape of home infusion and specialty care. This guide bre...
A notable fund exited its position in a medical device stock, locking in gains as the shares slipped over the past ye...
MP Materials is shaping the materials landscape with its Mountain Pass operation. This guide breaks down what to wat...
Investors are keen on LENZ as the company reports Q1 2026 earnings. This in-depth look breaks down the key numbers, w...
Investors are watching a niche player circle the AI data-center space. This small crypto miner is shifting gears, spa...
Three heavyweights are quietly reshaping how money moves across borders. Ripple, SWIFT and Visa are testing new rails...
A director at The Cheesecake Factory recently disclosed a sizable stock move. This guide breaks down what that inside...
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
As kickoff nears, hundreds of tickets for the U.S. opener sit unsold, while resale platforms show discounted options....
As SpaceX opens trading, savvy investors wonder how much upside the IPO price may still hold. This deep-dive walks th...
Kalshi is courting a lofty valuation after a recent funding round, signaling confidence in prediction markets amid a ...